Why the study?
Rising demand for longitudinal cardiovascular care in Singapore faced constraints from limited specialist accreditation pathways, uneven service distribution, and emerging digital requirements.
A physician-led, pharmacist-enabled model is proposed to support sustainable cardiovascular care, medication optimization, and transitions of care in Singapore.
Guides Singapore CV care implementation via pharmacist integration; extends multidisciplinary models to medication optimization and transitions.
Introduction: Cardiovascular disease remains a leading cause of morbidity and mortality in Singapore, with rising demand for longitudinal cardiovascular care driven by ageing and metabolic risk factors. Cardiology pharmacists support medication optimisation, transitions of care and patient education across hospital, ambulatory and community settings. However, limited specialist accreditation pathways, uneven service distribution and emerging digital requirements constrain scalable delivery to match national needs. Methods: This position paper was developed by the Pharmaceutical Society of Singapore Cardiology Pharmacy Working Group. A multidisciplinary consensus approach was adopted, guided by RIGHT and AGREE II principles to ensure transparency, applicability and editorial independence. Evidence synthesis drew from published literature, national epidemiology and institutional experience, contextualised within governance under the Healthcare Services Act and Collaborative Prescribing Agreement. Results: Cardiology pharmacists are essential to medication safety, adherence support and protocol-guided dose optimisation under physician oversight. Key gaps include delayed post-discharge follow-up, fragmented hospital-primary care alignment, telehealth implementation challenges and a limited pipeline of accredited specialists, restricting capacity to achieve guideline-directed therapy targets and sustained continuity of care. Conclusion: Five priorities were endorsed: strengthening specialist workforce capability; enhancing early postdischarge reviews; integrating pharmacists across care settings; leveraging digital-enabled care; and expanding medication-focused roles in prevention, atrial fibrillation, palliative heart failure and precision medicine. Cardiology pharmacists are critical contributors to a safe, coordinated and future-ready cardiovascular care ecosystem. A physician-led, pharmacist-enabled model supports national goals under Healthier SG.
No takes yet. Share an insight, caveat, or question.
Fletcher et al. (2025) conducted a review in Cardiovascular disease (Acute Myocardial Infarction, Heart Failure, Atrial Fibrillation). Physician-led, pharmacist-enabled model of care was evaluated. The projected cardiovascular disease burden in Singapore is expected to rise significantly by 2035, necessitating an expanded role for cardiology pharmacists to manage the increased clinical workload.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: